KIRA8 markedly reduced the viability of MM and B-derived, non-myeloma cancer cell lines in 3D culture settings, in contrast to 2D cultures of these cell lines that demonstrate significantly lower levels of IRE1α–XBP1s [84]. This evidence concerns the gene ERN1 and cancer.